Articles

• All
• CVD
• CKD
• Dialysis
• SGLT2i
• Hypertension
• Hyperglycaemia
• AKI
• RAAS
• Anaemia
• Transplantation

• 

  A FINE time to be a nephrologist

  30 Jun 2026

  • CKD
  • Hyperglycaemia
  • Editorial
  • CVD

• 

  Orforglipron versus dapagliflozin in type 2 diabetes

  28 Jun 2026

  • Hyperglycaemia

• 

  An integrated primary care model for cardiorenal-metabolic disease

  27 Jun 2026

  • CVD
  • CKD
  • Hyperglycaemia
  • Hypertension

• 

  Finerenone in type 1 diabetes and chronic kidney disease

  3 May 2026

  • CKD
  • CVD
  • Hyperglycaemia
  • RAAS

• 

  How low should we go? Optimal blood pressure targets for people with type 2 diabetes to reduce kidney and cardiovascular outcomes

  26 Feb 2026

  • Hypertension
  • CKD
  • Hyperglycaemia

• 

  Blood pressure levels and outcomes in type 2 diabetes

  25 Feb 2026

  • Hypertension
  • Other conditions
  • Hyperglycaemia

• 

  FINE-HEART: Effects of finerenone on morbidity and mortality in CKD

  3 Nov 2025

  • CKD
  • CVD
  • Hyperglycaemia

• 

  Use and safety of finerenone in a routine setting: first interim results from FINE-REAL

  26 Oct 2024

  • CKD
  • Hyperglycaemia

• 

  A promising FLOW of repurposed pharmacological therapies in people with CKD in type 2 diabetes

  12 Jul 2024

  • CKD
  • CVD
  • Hyperglycaemia
  • Editorial